LAGUNA HILLS, CA--(Marketwired - September 02, 2016) - Itonis, Inc. (OTC PINK: ITNS)
Itonis is pleased to announce that it has signed an agreement with Comcast Spotlight Washington to provide cable TV and digital video advertisements for its Emesyl® anti-nausea Homeopathic product.
The initial 4-week campaign in the DC market starts on September 5, and will run through October 2, 2016 with a newly designed 30 second commercial.
The newly designed commercial scheduled to air can be viewed here: http://www.itonisholdings.com/data/supporting_files/uploads/157c8c899f2339-emesyl_v02c.mp4
The campaign will run on multiple targeted TV networks in 12 separate advertising zones in the following areas: Howard County, North Anne Arundel County, Montgomery County, Prince George's County, Fairfax County, Loudoun County, DC, Arlington, and Alexandria. Audience reach includes Comcast households and those of Comcast Spotlight's media sales partners Verizon FiOS® and Cox®.
A detailed listing of the targeted TV networks and run times can be viewed here: http://www.itonisholdings.com/data/supporting_files/uploads/157c8d8db050fc-emesyl_metro_dc_sept_2016_commercial_run_times.pdf
The television campaign will be integrated with video pre-roll ads on Comcast Spotlight's targeted digital platform with impressions targeted to Health and Travel audiences across the DMA.
"We learned a lot from the run of our initial 10,000 commercial spots, which was coordinated via Neovix, Inc. The initial ads did not produce the results we had hoped to achieve, and based on their response we will not be doing any future business with them."
"The Comcast Spotlight cable TV campaign is focused on very specific demographics, and we are extremely excited to be working with them to create additional branding and retail sales for our anti-nausea Emesyl® product," said Steve Pidliskey, Itonis Vice President.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on the distribution of innovative products to the medical and pharmaceutical industries. The company also holds a licensing agreement with MyECheck Inc, which allows the company to use MyECheck's patented mobile payment application and share transaction revenue fees for point of purchase payments across various industries. Please visit www.itonisholdings.com for additional information.
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.